Kilitch Drugs (India) Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	2,355	1,983	1,544	1,396	1,142
Other Revenue	112.39	-	-	-	-
Revenue	2,467	1,983	1,544	1,396	1,142
Revenue Growth (YoY)	24.40%	28.47%	10.58%	22.20%	66.71%
Cost of Revenue	1,261	1,053	793.92	754.16	673.86
Gross Profit	1,206	930.05	749.8	641.83	468.49
Selling, General & Admin	357.08	312.74	239.66	231.58	117.14
Other Operating Expenses	370.34	302.66	262.1	234.61	234.96
Operating Expenses	763.65	638.08	526.82	493.27	368.33
Operating Income	442.15	291.97	222.98	148.56	100.16
Interest Expense	-55.61	-50.41	-59.29	-49.19	-11.98
Interest & Investment Income	-	36	4.2	3.1	2.5
Earnings From Equity Investments	-	0	0.02	0.02	-0.02
Currency Exchange Gain (Loss)	-	28.07	19.96	15.6	-2.29
Other Non Operating Income (Expenses)	-	7.93	0.22	0.59	2.62
EBT Excluding Unusual Items	386.54	313.57	188.09	118.69	90.98
Impairment of Goodwill	-	-8.43	-8.43	-8.43	-8.43
Gain (Loss) on Sale of Investments	-	39.6	13.89	9.88	13.59
Pretax Income	386.54	344.74	193.55	120.14	96.14
Income Tax Expense	91.54	95.34	57.79	37.32	34.01
Earnings From Continuing Operations	295	249.4	135.75	82.83	62.14
Minority Interest in Earnings	6.66	17.61	10.26	21.65	11.54
Net Income	301.66	267.01	146.01	104.48	73.67
Net Income to Common	301.66	267.01	146.01	104.48	73.67
Net Income Growth	12.98%	82.86%	39.75%	41.82%	100.68%
Shares Outstanding (Basic)	34	32	32	31	31
Shares Outstanding (Diluted)	34	32	32	31	31
Shares Change (YoY)	5.26%	0.96%	2.23%	0.10%	0.56%
EPS (Basic)	8.91	8.30	4.58	3.35	2.37
EPS (Diluted)	8.91	8.30	4.58	3.35	2.36
EPS Growth	7.35%	81.10%	36.71%	41.76%	99.58%
Free Cash Flow	-755.5	-293.31	-79.85	-12.26	-24.19
Free Cash Flow Per Share	-22.32	-9.12	-2.51	-0.39	-0.78
Gross Margin	48.88%	46.90%	48.57%	45.98%	41.01%
Operating Margin	17.92%	14.72%	14.44%	10.64%	8.77%
Profit Margin	12.23%	13.46%	9.46%	7.48%	6.45%
Free Cash Flow Margin	-30.62%	-14.79%	-5.17%	-0.88%	-2.12%
EBITDA	478.38	313.56	246.36	175.51	116.29
EBITDA Margin	19.39%	15.81%	15.96%	12.57%	10.18%
D&A For EBITDA	36.23	21.59	23.38	26.96	16.13
EBIT	442.15	291.97	222.98	148.56	100.16
EBIT Margin	17.92%	14.72%	14.44%	10.64%	8.77%
Effective Tax Rate	23.68%	27.66%	29.86%	31.06%	35.37%
Revenue as Reported	2,467	2,095	1,589	1,425	1,171

Source: S&P Global Market Intelligence. Standard template. Financial Sources.